ࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` 3 Table 2 O N Parameters IL-1 Receptor Antagonist p value T/T genotype C/T genotype Disease duration (years) 10.30 7.70 10.10 9.90 0.747 Positive RF, n(%) 43 (70.5) 12(75.0) 0.299 CRP (mg/dL) 0.53 0.67 1.30 2.02 <0.050 ESR (IU/ml)
44.65 23.40
48.00 27.30 0.757 HAQ DI HAQ < 1, n(%) 59 (96.7) 15 (93.7) 0.138
H A Q e" 1 , n ( % ) 2 (3.3) 1 (6.3) MSS 4.22 8.74
24.44 10.71 0.004 Swollen joint count 0.92 1.92 1.69 0.95 0.033 Tender joint count 0.69 1.46 1.19 1.17 0.907 VAS 3.582.12 3.061.84 0.446
DAS 28 scores 2.031.15 2.790.89 0.017 Disease Activity R e m i s s i o n l o w , n ( % ) 52 (85) 11 (64.5) 0.183 M o d e r a t e h i g h , n ( % ) 9 (14.7) 5 (35.5)
Medications, n(%) 0.597 Methotrexate
44 (72.00)
11 (68.80) Leflunomide
23 (37.70) 3(18.75)
Sulfasalazine
14 (23.00) 7 (43.75) Hydroxychloroquine 6 (9.80) 1 (6.25) Prednisolone 1 (1.60) 4 (25.00) Biologics 3 (4.90) 1(6.25)
d MbP?_ % * + &P &F